GlucoTrack
GCTK · NASDAQ
$0.6511−$0.0336 (−4.91%)TodayMarket closed ·
Prev close $0.6847
Who owns GCTK
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 1.5% of GCTK’s shares.
- RXRR Capital Partners0.5%
- Apimeds Pharmaceuticals US Inc0.5%
- HRT Financial LP0.2%
- Jane Street Capital, L.L.C.0.1%
- Next 6 largest institutions0.3%
- All other shareholders98.5%
| Holder | Shares | % of shares |
|---|---|---|
| RXRR Capital Partners | 39.43K | 0.51% |
| Apimeds Pharmaceuticals US Inc | 37.88K | 0.49% |
| HRT Financial LP | 13.70K | 0.18% |
| Jane Street Capital, L.L.C. | 8.56K | 0.11% |
| Armistice Capital LLC | 6.81K | 0.09% |
| Citadel Advisors LLC | 5.30K | 0.07% |
| Ikarian Capital LLC | 3.06K | 0.04% |
| Geode Capital Management, L.L.C. | 2.28K | 0.03% |
| Virtu Americas LLC | 1.25K | 0.02% |
| Granite Islands Private Wealth, LLC | 1.05K | 0.01% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 2.22K | 0.03% |
| Abante Quant Value, FI | 604 | 0.01% |
| Fidelity Series Total Market Index Fund | 30 | 0.00% |
Short interest
Settled Sep 30, 2026
- Shares short
- 122.11K
- Days to cover
- 1.00
- % of shares outstanding
- 1.58%
- Average daily volume
- 7.39M
- Change since last report
- +26.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.